Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest Up 143.3% in February

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZGet Free Report) saw a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 98,300 shares, an increase of 143.3% from the January 31st total of 40,400 shares. Currently, 5.8% of the shares of the company are sold short. Based on an average daily volume of 64,300 shares, the days-to-cover ratio is presently 1.5 days.

Creative Medical Technology Trading Down 1.6 %

Shares of CELZ stock opened at $4.97 on Friday. The firm has a market capitalization of $8.69 million, a P/E ratio of -1.31 and a beta of 1.85. Creative Medical Technology has a 1 year low of $1.96 and a 1 year high of $10.28. The firm’s fifty day simple moving average is $3.29 and its 200 day simple moving average is $3.21.

Hedge Funds Weigh In On Creative Medical Technology

An institutional investor recently bought a new position in Creative Medical Technology stock. Geode Capital Management LLC purchased a new stake in shares of Creative Medical Technology Holdings, Inc. (NASDAQ:CELZFree Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,308 shares of the company’s stock, valued at approximately $25,000. Geode Capital Management LLC owned approximately 0.59% of Creative Medical Technology at the end of the most recent reporting period. Hedge funds and other institutional investors own 1.42% of the company’s stock.

About Creative Medical Technology

(Get Free Report)

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.

See Also

Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.